Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Interim Management Statement

29 Oct 2009 07:00

RNS Number : 5476B
Alumasc Group PLC
29 October 2009
 



Thursday 29 October 2009 

THE ALUMASC GROUP PLC - INTERIM MANAGEMENT STATEMENT

Alumasc, the premium building and engineering products company, is publishing its first interim management statement for the year ending 30 June 2010 to coincide with its Annual General Meeting being held in London at 10.30am today.

 

Trading from 1 July to date has been in line with the Board's expectations. Overall activity levels have been stable when compared with the final quarter of the previous financial year, albeit group revenues in the first quarter remained well below the first quarter of the prior yearwhich preceded the impact of the recession on the group.

The principal factors affecting trading so far in this financial year have been those anticipated in the Report and Accounts 2009, namely:

a further reduction in demand for new build commercial buildings, mitigated by Alumasc's sustainable building product activities, which continue to perform relatively well;

broadly stable demand for public sector new build and refurbishment work;

a modest upturn in demand from the new house building sector;

continued quiet market conditions in the brewing sector;

stable to slightly improved demand from international OEMs for precision engineering products following de-stocking in the second half of the previous financial year; and

moves by customers to consolidate their supplier bases, a trend we believe will benefit the group's precision engineering businesses.

The group's operating margins are benefiting from the £6 million of annualised cost savingdelivered in the last financial year, and from further operating efficiencies and control over discretionary spend in the current year. 

Progress on improving the performance of Alumasc Precision Components, the larger of the group's precision engineering businesses, has been very encouraging and enquiry levels for further new work remain high.

Work continues to build the foundations for an increased level of export sales by Levolux and Gatic into the USAWhilst this activity, in the main, is expected to benefit the next financial year and beyond, it may also bring opportunities towards the end of the current financial year.

The group's cash performance has been positive, with net debt at 30 September 2009 of £9.0 million, £1.3 million lower than at 30 June. This represents gearing of around 30%.

There have been no significant changes to the group's balance sheet since 30 June 2009, and there have been no significant non-recurring items impacting the income statement.

The Board continues to believe that Alumasc remains well placed to manage through the rest of the recession, benefit from the opportunities that this brings and emerge a stronger group as economic conditions improve.

Presentation:

On Wednesday 11 November 2009, from 13.00 to 14.00, over a sandwich lunch, Paul Hooper (CEO) and Andrew Magson (GFD) will be presenting to private client brokers and others professionally interested in ALU. The location is the offices of Bankside Consultants, 1 Frederick's Place, LondonEC2R 8AE. Those wishing to attend are asked to reply to Charles Ponsonby of Bankside Consultants by email (charles.ponsonby@bankside.com), fax (020-7367 8899), or telephone (020-7367 8851).

Enquiries:

The Alumasc Group plc

Paul Hooper (Group Chief Executive)  Tel: 01536 383821

Andrew Magson (Group Finance Director)  Tel: 01536 383844

Bankside Consultants

Charles Ponsonby Tel: 0207 367 8851/07789 202 312

Rose Oddy Tel: 0207 367 8853

This Interim Management Statement has been drawn up and presented for the purposes of complying with English law. Any liability arising out of or in connection with this Interim Management Statement will also be determined in accordance with English law.

This Interim Management Statement may contain 'forward-looking statements'. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Many of these risks and uncertainties relate to factors beyond The Alumasc Group's control or which cannot be estimated precisely, such as future market conditions and the behaviour of the market participants. Actual outcomes and results may therefore differ materially from any outcomes or results expressed or implied by any such forward-looking statements.

Nothing in this Interim Management Statement is intended to be a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDVLFLKBBBFBQ
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.